Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Oxford Immunotec Global stock

Learn how to easily invest in Oxford Immunotec Global stock.

Oxford Immunotec Global PLC
NASDAQ: OXFD - USD
DIAGNOSTICS & RESEARCH
$0
-

Oxford Immunotec Global PLC is a diagnostics & research business based in the US. Oxford Immunotec Global shares (OXFD) are listed on the NASDAQ and all prices are listed in US Dollars. Oxford Immunotec Global employs 273 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Oxford Immunotec Global

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OXFD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Oxford Immunotec Global stock price (NASDAQ: OXFD)

Use our graph to track the performance of OXFD stocks over time.

Oxford Immunotec Global shares at a glance

Information last updated 2021-05-02.
52-week range$10.98 - $23.11
50-day moving average $21.94
200-day moving average $16.48
Wall St. target price$22.50
PE ratio 11.746
Dividend yield N/A (0%)
Earnings per share (TTM) $5.18

Buy Oxford Immunotec Global shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Oxford Immunotec Global stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Oxford Immunotec Global under- or over-valued?

Valuing Oxford Immunotec Global stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Oxford Immunotec Global's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Oxford Immunotec Global's P/E ratio

Oxford Immunotec Global's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Oxford Immunotec Global shares trade at around 12x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Oxford Immunotec Global financials

Revenue TTM $57.3 million
Gross profit TTM $54.4 million
Return on assets TTM -4.99%
Return on equity TTM -8.19%
Profit margin -30.51%
Book value $7.37
Market capitalisation $562.5 million

TTM: trailing 12 months

Shorting Oxford Immunotec Global shares

There are currently 136,459 Oxford Immunotec Global shares held short by investors – that's known as Oxford Immunotec Global's "short interest". This figure is 11.1% down from 153,441 last month.

There are a few different ways that this level of interest in shorting Oxford Immunotec Global shares can be evaluated.

Oxford Immunotec Global's "short interest ratio" (SIR)

Oxford Immunotec Global's "short interest ratio" (SIR) is the quantity of Oxford Immunotec Global shares currently shorted divided by the average quantity of Oxford Immunotec Global shares traded daily (recently around 974707.14285714). Oxford Immunotec Global's SIR currently stands at 0.14. In other words for every 100,000 Oxford Immunotec Global shares traded daily on the market, roughly 140 shares are currently held short.

However Oxford Immunotec Global's short interest can also be evaluated against the total number of Oxford Immunotec Global shares, or, against the total number of tradable Oxford Immunotec Global shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Oxford Immunotec Global's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Oxford Immunotec Global shares in existence, roughly 10 shares are currently held short) or 0.0077% of the tradable shares (for every 100,000 tradable Oxford Immunotec Global shares, roughly 8 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Oxford Immunotec Global.

Find out more about how you can short Oxford Immunotec Global stock.

Oxford Immunotec Global share dividends

We're not expecting Oxford Immunotec Global to pay a dividend over the next 12 months.

Oxford Immunotec Global share price volatility

Over the last 12 months, Oxford Immunotec Global's shares have ranged in value from as little as $10.98 up to $23.1081. A popular way to gauge a stock's volatility is its "beta".

OXFD.US volatility(beta: 1.38)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oxford Immunotec Global's is 1.3781. This would suggest that Oxford Immunotec Global's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Oxford Immunotec Global overview

Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States, Europe, Asia, and internationally. The company develops its products using its T-SPOT technology platform that measures marker-specific cellular (T cells) responses at a single cell level and inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. It develops and markets T-SPOT. TB test used to test for tuberculosis; and reagents and methods to purify white blood cells for use in immunology assays. In addition, the company offers T-SPOT. CMV, an immune monitoring test for cytomegalovirus (CMV) for the quantification of effector T cells that respond to stimulation by antigens specific for CMV, as well as for the monitoring of CMV-seropositive responses in transplant recipients at various time-points post-transplantation applications. It serves independent laboratories, hospital systems, and public and private institutions.

Stocks similar to Oxford Immunotec Global

Oxford Immunotec Global in the news

There are no recent company news

Frequently asked questions

What percentage of Oxford Immunotec Global is owned by insiders or institutions?
Currently 1.894% of Oxford Immunotec Global shares are held by insiders and 95.723% by institutions.
How many people work for Oxford Immunotec Global?
Latest data suggests 273 work at Oxford Immunotec Global.
When does the fiscal year end for Oxford Immunotec Global?
Oxford Immunotec Global's fiscal year ends in December.
Where is Oxford Immunotec Global based?
Oxford Immunotec Global's address is: 143 Park Drive, Abingdon, United Kingdom, OX14 4SE
What is Oxford Immunotec Global's ISIN number?
Oxford Immunotec Global's international securities identification number is: GB00BGFBB958
What is Oxford Immunotec Global's CUSIP number?
Oxford Immunotec Global's Committee on Uniform Securities Identification Procedures number is: G6855A103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site